Cell Development Research Act of 2001

This bill would require the Food and Drug Administration (FDA) to create a specialized panel of experts dedicated to the field of cell development and embryology. This panel would be responsible for providing scientific advice on the testing and approval of new drugs derived from embryonic research, while also making policy recommendations to encourage further scientific advancement in the field. For the average citizen, this legislation aims to streamline the development of new medical treatments by ensuring the FDA has a consistent, expert body to evaluate the safety and effectiveness of cell-based therapies. The bill specifically notes that this panel would not have the authority to regulate or make recommendations regarding fertility medicine or reproductive practices.